Anti-HIV agent 1592U89 succinate - progress from synthesis through clinical development: S. M. Daluge, S. W. LaFon, S. S. Good, M. H. St. Clair., D. A. Livingston, M. T. Martin. Glaxo Wellcome, Research Triangle Park, NC, 27709, USA

Zdroj:	In Antiviral Research 1996 30(1):A17-A17
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect